Showing 1651-1660 of 2652 results for "".
- Oyster Point Pharma Announces Tyrvaya Nasal Spray Now Covered by Express Scriptshttps://modernod.com/news/oyster-point-pharma-announces-tyrvaya-nasal-spray-now-covered-by-express-scripts/2480656/Oyster Point Pharma announced Tyrvaya Nasal Spray’s placement on the Express Scripts National Preferred, Basic, and High Performance Formularies, which collectively covers an estimated 26 million people, effective February 19, 2022. Tyrvaya is the first and only na
- Hovione Completes Phase 2 Clinical Trial of First Minocycline Ophthalmic for Dry Eye Disease Associated With Inflamed MGDhttps://modernod.com/news/hovione-completes-phase-2-clinical-trial-of-first-minocycline-ophthalmic-showing-promise-in-dry-eye-disease-associated-with-inflamed-mgd/2478986/Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its phase 2 clinical trial in 270 patients with dry eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative study was conducted across 26 clinical sites in
- Novavax’s COVID-19 Vaccine Over 89% Effective in UK trial, Less So in South Africa Studyhttps://modernod.com/news/novavaxs-covid-19-vaccine-over-89-effective-in-uk-trial-less-so-in-south-africa-study/2478809/Novavax shares gained as much as 26% on Thursday after the company said its protein-based COVID-19 vaccine candidate NVX-CoV2373 met the primary endpoint of a phase 3 trial in the UK, demonstrating an efficacy rate of over 89%, with high protection also seen against the fast-spreading UK variant.
- FDA Accepts Santen’s NDA for Cyclosporine Topical Ophthalmic Emulsion for the Treatment of Severe Vernal Keratoconjunctivitis in Patients Ages 4-18https://modernod.com/news/fda-accepts-santens-nda-for-cyclosporine-topical-ophthalmic-emulsion-for-the-treatment-of-severe-vernal-keratoconjunctivitis-in-patients-ages-4-18/2478457/Santen announced that the FDA has accepted the new drug application (NDA) for cyclosporine topical ophthalmic emulsion 0.1% for the treatment of severe vernal keratoconjunctivitis (VKC) in patients ages 4-18. The FDA has set June 26, 2021 as the Prescription Drug Use
- Bausch + Lomb Introduces Pinnacle 360 25-Gauge Scleral Fixation Forcepshttps://modernod.com/news/bausch-lomb-introduces-pinnacle-360-25-gauge-scleral-fixation-forceps/2478053/Bausch + Lomb announced the introduction of the new Pinnacle 360 25-gauge Scleral Fixation Forceps. Bausch + Lomb will feature this innovation, as well as others in the company’s retina portfolio, during the virtual American Society of Retinal Specialists (ASRS) annual meeting, July 24-26, 2020.<
- Alcon to Showcase Latest Innovations, Data at ASRS 2020 Virtual Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-data-at-asrs-2020-virtual-annual-meeting/2478040/Alcon will present key data highlighting advancements in vitreoretinal surgery during the American Society of Retina Specialists (ASRS) 2020 virtual annual meeting, taking place July 24-26. New data about the effectiveness of the Hypervit Dual Blade Vitrectomy Probe and other retina surgical plat
- Vision Expo West 2020 Cancelled; Virtual Offerings Plannedhttps://modernod.com/news/vision-expo-west-2020-cancelled-new-virtual-offerings-planned/2477995/The Vision Council and Reed Exhibitions, organizers of Vision Expo, announced the decision to cancel Vision Expo West 2020, scheduled to take place in Las Vegas from September 23-26. “Over the past several months, Reed Exhibitions’ Vision Expo team and The Vision Council worked toget
- 2020 World Ophthalmology Congress Cancelled; Virtual Program Plannedhttps://modernod.com/news/2020-world-ophthalmology-congress-cancelled-virtual-program-planned/2479534/Due to the COVID-19 pandemic, The International Council of Ophthalmology (ICO) has decided to cancel the World Ophthalmology Congress (WOC2020), scheduled to take place June 26-29, in Cape Town, Africa. In a message to its members, ICO leadership stated that it remains devoted to bringing
- Working With BARDA and FDA on COVID-19 Countermeasureshttps://modernod.com/news/covid-19-working-with-barda-and-fda-on-covid-19-countermeasures/2477443/How can biotech and pharmaceutical companies work with the government in developing and supplying effective diagnostics, treatments and vaccines for COVID-19? What should these companies know? Join Arnold & Porter on Thursday, March 26 from 12–2 pm Eastern Time for an introduction to c
- Vit-Buckle Society Annual Meeting Cancelledhttps://modernod.com/news/vit-buckle-society-annual-meeting-cancelled/2477432/The Board of Trustees and the Executive Committee of the Vit-Buckle Society (VBS) said that its annual meeting, originally scheduled for March 26-28 in Miami, has been officially cancelled, according to a email sent to its members on Friday. Previously, the meeting was designated as postposed.